BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34265288)

  • 1. Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers.
    Yu S; Li Q; Wang Y; Cui Y; Yu Y; Li W; Liu F; Liu T
    Exp Cell Res; 2021 Sep; 406(1):112734. PubMed ID: 34265288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.
    Yu S; Li Q; Yu Y; Cui Y; Li W; Liu T; Liu F
    Cancer Immunol Immunother; 2020 Oct; 69(10):1973-1987. PubMed ID: 32388677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.
    Xu G; Wang H; Li W; Xue Z; Luo Q
    J Cell Physiol; 2019 Apr; 234(4):3613-3620. PubMed ID: 30565675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophage-derived CCL5 promotes chemotherapy resistance and metastasis in prostatic cancer.
    Ma J; Shayiti F; Ma J; Wei M; Hua T; Zhang R; Su J; Chen P
    Cell Biol Int; 2021 Oct; 45(10):2054-2062. PubMed ID: 34003531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages.
    He Z; Chen D; Wu J; Sui C; Deng X; Zhang P; Chen Z; Liu D; Yu J; Shi J; Li G; Yao X
    Arch Biochem Biophys; 2021 May; 702():108838. PubMed ID: 33727040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer.
    Lin XM; Li S; Zhou C; Li RZ; Wang H; Luo W; Huang YS; Chen LK; Cai JL; Wang TX; Zhang QH; Cao H; Wu XP
    Int J Biochem Cell Biol; 2019 Nov; 116():105610. PubMed ID: 31518663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.
    Di Giorgio C; Bellini R; Lupia A; Massa C; Urbani G; Bordoni M; Marchianò S; Rosselli R; De Gregorio R; Rapacciuolo P; Sepe V; Morretta E; Monti MC; Moraca F; Cari L; Ullah KRS; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
    Cell Oncol (Dordr); 2024 Apr; 47(2):695-710. PubMed ID: 37945798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF1α promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer.
    Zheng H; Yu S; Zhu C; Guo T; Liu F; Xu Y
    Exp Cell Res; 2021 Jan; 398(2):112394. PubMed ID: 33242463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
    Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
    Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
    Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y
    Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
    Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
    An Y; Wang B; Wang X; Dong G; Jia J; Yang Q
    Cell Death Dis; 2020 Feb; 11(2):115. PubMed ID: 32051395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
    Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
    Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
    Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
    Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1 alpha inhibits self-renewal of mouse embryonic stem cells in Vitro via negative regulation of the leukemia inhibitory factor-STAT3 pathway.
    Jeong CH; Lee HJ; Cha JH; Kim JH; Kim KR; Kim JH; Yoon DK; Kim KW
    J Biol Chem; 2007 May; 282(18):13672-9. PubMed ID: 17360716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis.
    Hu C; Xia R; Zhang X; Li T; Ye Y; Li G; He R; Li Z; Lin Q; Zheng S; Chen R
    Mol Cancer; 2022 Jan; 21(1):24. PubMed ID: 35045883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Overexpression of leukemia inhibitory factor enhances chemotherapy tolerance of endometrial cancer cells
    Ruan X; Zhong M; Liu W; Liu Q; Lu W; Zheng Y; Zhang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):20-26. PubMed ID: 32376564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.